Article
Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
American journal of medical genetics. Part A - 1 May 2017
Bertola Débora, Buscarilli Michelle, Stabley Deborah L, Baker Laura, Doyle Daniel, Bartholomew Dennis W, Sol-Church Katia, Gripp Karen W
Abstract excerpt
Costello syndrome is part of the RASopathies, a group of neurocardiofaciocutaneous syndromes caused by deregulation of the RAS mitogen-activated protein kinase pathway. Heterozygous mutations in HRAS are responsible for Costello syndrome, with more than 80% of the patients harboring the specific p.Gly12Ser variant. These individuals show a homogeneous phenotype. The clinical characteristics of the Costello...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
